公开(公告)号：US11207310B2

公开(公告)日：2021-12-28

申请号：US15685993

申请日：2017-08-24

Applicant: PRILENIA NEUROTHERAPEUTICS LTD.

Inventor： Michael Hayden ,  Spyridon Papapetropoulos ,  Juha-Matti Savola ,  Eli Eyal ,  Beth Borowsky ,  Igor Grachev

IPC: A61K31/451 ,  A61K9/00

Abstract: This invention provides a method of maintaining functional capacity, improving functional capacity, or lessening the decline of functional capacity in a human patient comprising periodically orally administering to the patient a pharmaceutical composition comprising pridopidine such that a dose of 90-225 mg of pridopidine is administered to the patient per day, so as to thereby maintain functional capacity, improve functional capacity, or lessen the decline of functional capacity in the human patient.

公开(公告)号：US20210308115A1

公开(公告)日：2021-10-07

申请号：US17352305

申请日：2021-06-20

Applicant: PRILENIA NEUROTHERAPEUTICS LTD.

Inventor： Merav Bassan ,  Esther Lukasiewicz Hagai ,  Eli Eyal ,  Anna Kristina Sveinsdotter Teige Wickenberg

IPC: A61K31/451 ,  A61P25/28 ,  A61K9/00

Abstract: A method of treating a human patient afflicted with Huntington's disease, comprising periodically orally administering to the patient a pharmaceutical composition comprising pridopidine, its analog or a pharmaceutically acceptable salt thereof.

公开(公告)号：US11090297B2

公开(公告)日：2021-08-17

申请号：US16438508

申请日：2019-06-12

Applicant: PRILENIA NEUROTHERAPEUTICS LTD.

Inventor： Merav Bassan ,  Esther Lukasiewicz Hagai ,  Eli Eyal ,  Anna Kristina Sveinsdotter Teige Wickenberg

IPC: A61K31/451 ,  A61P25/28 ,  A61K9/00

Abstract: A method of treating a human patient afflicted with Huntington's disease, comprising periodically orally administering to the patient a pharmaceutical composition comprising pridopidine, its analog or a pharmaceutically acceptable salt thereof.

公开(公告)号：US20190350915A1

公开(公告)日：2019-11-21

申请号：US16438508

申请日：2019-06-12

Applicant: PRILENIA NEUROTHERAPEUTICS LTD.

Inventor： Merav BASSAN ,  Esther Lukasiewicz Hagai ,  Eli Eyal ,  Anna Kristina Sveinsdotter Teige Wickenberg

IPC: A61K31/451 ,  A61K9/00 ,  A61P25/28

Abstract: A method of treating a human patient afflicted with Huntington's disease, comprising periodically orally administering to the patient a pharmaceutical composition comprising pridopidine, its analog or a pharmaceutically acceptable salt thereof.